
|
Report Date : |
03.05.2007 |
IDENTIFICATION DETAILS
|
Name : |
QUANG NAM
PHARMACEUTICAL MEDICAL MATERIAL JOINT STOCK COMPANY |
|
|
|
|
Registered Office : |
No. 120 Huynh Thuc Khang Str., Xuan An Ward, Tam Ky Town, Quang Nam Province
|
|
|
|
|
Country : |
|
|
|
|
|
Date of Incorporation : |
1997 |
|
|
|
|
Legal Form : |
Joint Stock Company |
|
|
|
|
Line of Business : |
Manufacture, trading, export and import of pharmaceutical products, medicine,
medical material, chemical and cosmetic. |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
|
SUBJECT
IDENTIFICATION & LEGAL FORM |
|||||||
|
|
|||||||
English Name
|
|
QUANG NAM PHARMACEUTICAL MEDICAL MATERIAL JOINT
STOCK COMPANY
|
|||||
Known
as
|
|
QUANG NAM PHARMACEUTICAL MEDICAL EQUIPMENT JOINT
STOCK COMPANY
|
|||||
|
Vietnamese name |
|
CONG TY CO PHAN DUOC VAT TU Y TE QUANG |
|||||
|
Trade Name |
|
QUANAPHARCO |
|||||
|
Type of Business |
|
Joint Stock
Company |
|||||
|
Founded |
|
1997 |
|||||
|
Establishment Decision |
|
No. 1776/QD-UB |
|||||
|
Issued on |
|
September 16th
1997 |
|||||
|
Issued by |
|
Quang Nam
People’s Committee |
|||||
|
Equitization Decision |
|
No. 4962/QD-UB |
|||||
|
Issued on |
|
November 29th
2004 |
|||||
|
Issued by |
|
Quang Nam
People’s Committee |
|||||
|
Business Registration |
|
No. 3303070106 |
|||||
|
Issued on |
|
January 31st
2005 |
|||||
|
Issued by |
|
Quang Nam
Department of Planning and Investment |
|||||
|
Registered Capital |
|
6,900,000,000 VND |
|||||
|
Tax Code |
|
4000101252 |
|||||
|
Total Employees |
|
287 persons |
|||||
|
Qualification |
|
Fairly Good |
|||||
|
|
|||||||
|
|
|||||||
|
ADDRESS |
|||||||
Head Office
|
|||||||
|
Address |
|
No. 120 Huynh Thuc Khang Str., Xuan An
Ward, Tam Ky Town, Quang Nam Province, Vietnam |
|||||
|
Tel |
|
(84-510) 812010 |
|||||
|
Fax |
|
(84-510) 828189 |
|||||
|
Note: The subject has 12 branches in all districts of |
|||||||
|
|
|||||||
|
|
|||||||
|
DIRECTORS |
|||||||
|
|
|||||||
|
1.
NAME |
|
Mr.
LE VAN QUANG |
|||||
|
Position |
|
Director |
|||||
|
Contact Address |
|
No. 120 Huynh Thuc Khang Str., Xuan An
Ward, Tam Ky Town, Quang Nam Province |
|||||
|
Nationality |
|
Vietnamese |
|||||
|
|
|||||||
|
2.
NAME |
|
Mr.
NGUYEN DINH TANG |
|||||
|
Position |
|
Vice Director |
|||||
|
Contact Address |
|
No. 120 Huynh Thuc Khang Str., Xuan An
Ward, Tam Ky Town, Quang Nam Province |
|||||
|
Nationality |
|
Vietnamese |
|||||
|
|
|||||||
|
3.
NAME |
|
Mr.
BUI VAN TRINH |
|||||
|
Position |
|
Vice Director |
|||||
|
Contact Address |
|
No. 120 Huynh Thuc Khang Str., Xuan An
Ward, Tam Ky Town, Quang Nam Province |
|||||
|
Nationality |
|
Vietnamese |
|||||
|
|
|||||||
|
|
|||||||
|
BUSINESS NATURE AND
ACTIVITIES |
|||||||
|
The subject registered in the following lines of business: |
|||||||
|
-
Manufacture, trading, export and import of
pharmaceutical products, medicine, medical material, chemical, and cosmetic. |
|||||||
|
Note: The subject mainly imports and trades in pharmaceutical from foreign markets. The subject is also producing some basics chemical for healthcare. |
|||||||
|
|
|||||||
|
|
|||||||
|
IMPORT & EXPORT
ACTIVITIES |
|||||||
|
|
|||||||
|
IMPORT: The subject
imports from |
|||||||
|
EXPORT: N/A |
|||||||
|
|
|||||||
|
|
|||||||
|
BANKERS |
|||||||
|
|
|||||||
|
1. NAME |
|
VIETNAM BANK FOR AGRICULTURAL & RURAL
DEVELOPMENT - QUANG |
|||||
|
Address |
|
No.6 Phan Boi
Chau Str., |
|||||
|
Tel |
|
(84-510) 852265 |
|||||
|
Fax |
|
(84-510) 851812 |
|||||
|
Account No. |
|
431101000149 |
|||||
|
|
|||||||
|
2. NAME |
|
INCOMBANK – QUANG |
|||||
|
Address |
|
No.22 Phan Boi
Chau Str, |
|||||
|
Tel |
|
(84-510) 851414 |
|||||
|
Fax |
|
(84-510) 851080 |
|||||
|
Account No |
|
10020000044702 |
|||||
|
|
|||||||
|
3. NAME |
|
BIDV – QUANG
|
|||||
|
Address |
|
No.4 Phan Boi
Chau Str, |
|||||
|
Country |
|
|
|||||
|
Tel |
|
(84-510) 834030 |
|||||
|
Fax |
|
(84-510) 859064 |
|||||
|
|
|||||||
|
|
|||||||
|
SHAREHOLDERS |
|||||||
|
|
|||||||
|
1.
NAME |
|
QUANG
|
|||||
|
Represented by |
|
Mr. LE VAN QUANG |
|||||
|
Position |
|
Director |
|||||
|
Contact Address |
|
No. 120 Huynh Thuc Khang Str., Xuan An
Ward, Tam Ki Town, |
|||||
|
Nationality |
|
Vietnamese |
|||||
|
Share |
|
51 percent |
|||||
|
|
|||||||
|
2.
NAME |
|
STAFFS AND OTHER
SHAREHOLDERS |
|||||
|
Position |
|
Shareholders |
|||||
|
Share |
|
49 percent |
|||||
|
|
|||||||
|
|
|||||||
|
PAYMENT HISTORY AND
EXPERIENCES |
|||||||
|
|
|||||||
|
Trade Morality |
|
Fair |
|||||
|
Liquidity |
|
Average |
|||||
|
Payments |
|
Fair prompt |
|||||
|
Financial Situation |
|
Fairly good |
|||||
|
Development trend |
|
Good |
|||||
|
Litigation Data |
|
No reported |
|||||
|
Bankruptcy |
|
No reported |
|||||
|
Payment Method |
|
TT, L/C |
|||||
|
|
|
Supplying For Customer And Projects |
|||||
|
|
|||||||
|
|
|||||||
|
FINANCIAL DATA |
|||||||
|
According to Chief accountant
of the subject, in 2006, revenue is about 188,000,000,000 VND and its profit
is 889,000,000 VND. The full financial statement in 2005 is not available,
following is financial highlight. |
|||||||
|
Unit: 1,000,000VND |
|||||||
|
Description |
2005 |
||||||
|
Current assets & Short term Investment |
74,282 |
||||||
|
Fixed assets & Long term investment |
3,570 |
||||||
Total
Assets
|
77,852 |
||||||
|
Payables |
69,623 |
||||||
|
Owner’s Equity |
8,229 |
||||||
Total
Liability And Equity
|
77,852 |
||||||
|
|
|
||||||
|
Total revenue |
142,877
|
||||||
|
Deductions
Items |
1,594
|
||||||
|
Net revenue |
141,283
|
||||||
|
Net income from
business activity |
396
|
||||||
|
Net income from
financial operation |
-1,452
|
||||||
|
Irregular
Profit |
1,888
|
||||||
|
Total pre-tax
profit |
832
|
||||||
|
|
|||||||
|
|
|||||||
|
BALANCE SHEET |
|||||||
Unit: VND million
|
|||||||
|
Balance sheet
date |
31/12/2004 |
31/12/2003 |
|||||
|
Number of weeks |
52 |
52 |
|||||
ASSETS
|
|||||||
|
A.
Working assets & short-term Investment |
55,078 |
43,992 |
|||||
|
I.
Cash and cash equivalents |
2,073 |
2,654 |
|||||
|
II.
Short-term investment |
0 |
0 |
|||||
|
1. Short-term securities
investment |
0 |
0 |
|||||
|
2. Other short-term investment |
0 |
0 |
|||||
|
3. Provision for short-term
investment |
0 |
0 |
|||||
|
III.
Receivables |
27,285 |
21,777 |
|||||
|
1. Receivables from customers |
9,523 |
10,870 |
|||||
|
2. Prepayment for providers |
0 |
1 |
|||||
|
3. Value-added tax deducted |
977 |
236 |
|||||
|
4. Internal receivables |
16,239 |
10,497 |
|||||
|
5. Other receivables |
546 |
173 |
|||||
|
6. Provision for bad
receivables |
0 |
0 |
|||||
|
IV. Inventory |
24,783 |
18,985 |
|||||
|
1.
Purchased goods in transit |
0 |
6 |
|||||
|
2. Raw materials |
31 |
22 |
|||||
|
3. Instrument, tools |
93 |
3 |
|||||
|
4. Cost for production and
business in process |
0 |
0 |
|||||
|
5. End products |
0 |
0 |
|||||
|
6. Goods |
24,659 |
18,955 |
|||||
|
7. Goods on consignment |
0 |
-1 |
|||||
|
8. Provision for devaluation of
stocks |
0 |
0 |
|||||
|
V. Other current assets |
937 |
576 |
|||||
|
1. Advances |
198 |
473 |
|||||
|
2. Prepaid expenses |
55 |
51 |
|||||
|
3. Pending expenses for
transfer |
633 |
1 |
|||||
|
4. Pending assets |
0 |
0 |
|||||
|
5. Mortgage, collateral and
short run collateral |
51 |
51 |
|||||
VI.
Administrative
|
0 |
0 |
|||||
1. Administrative expenses for
previous year
|
0 |
0 |
|||||
2. Administrative expenses for
current year
|
0 |
0 |
|||||
|
B. Fixed assets
& Long term investment |
3,461 |
4,639 |
|||||
|
I. Fixed assets |
2,777 |
4,614 |
|||||
|
1. Tangible fixed assets |
2,777 |
4,609 |
|||||
|
+ Original cost |
4,701 |
6,210 |
|||||
|
+ Accumulated depreciation
value |
-1,924 |
-1,601 |
|||||
|
2. Financial leasing fixed
assets |
0 |
5 |
|||||
|
+ Original cost |
0 |
5 |
|||||
|
+ Accumulated depreciation
value |
0 |
0 |
|||||
|
3. Intangible fixed assets |
0 |
0 |
|||||
|
+ Original cost |
0 |
0 |
|||||
|
+ Accumulated depreciation
value |
0 |
0 |
|||||
|
II. Long term
investment |
0 |
3 |
|||||
|
1. Long-term securities investment |
0 |
0 |
|||||
|
2. Joint-venture capital contribution |
0 |
0 |
|||||
|
3. Other long-term investment |
0 |
3 |
|||||
|
4. Provision for long-term investment devaluation |
0 |
0 |
|||||
|
III. Capital
construction in process |
668 |
9 |
|||||
|
IV. Other |
16 |
13 |
|||||
|
TOTAL ASSETS |
58,539 |
48,631 |
|||||
LIABILITIES
|
|||||||
|
A.
Payable loans |
51,268 |
43,088 |
|||||
|
I. Short term
payables |
50,725 |
42,168 |
|||||
|
1. Short-term borrowings |
17,678 |
17,986 |
|||||
|
2. Due long-term liabilities |
0 |
0 |
|||||
|
3. Payables to supplier |
15,939 |
11,947 |
|||||
|
4. Prepayment of buyer |
10 |
437 |
|||||
|
5. Taxes and accounts dutiable |
43 |
570 |
|||||
|
6. Employee payments |
297 |
554 |
|||||
|
7. Internal payables |
16,239 |
10,498 |
|||||
|
8. Other payables |
519 |
176 |
|||||
|
II. Long term loans |
114 |
633 |
|||||
|
1. Long-term borrowings |
114 |
633 |
|||||
|
2. Long-term payables |
0 |
0 |
|||||
|
III. Other
payables |
429 |
287 |
|||||
|
1. Payable expenses |
271 |
128 |
|||||
|
2. Pending assets |
0 |
0 |
|||||
|
3. Receipts long-term collateral and deposit |
158 |
159 |
|||||
|
B. Owner’s
Equity |
7,271 |
5,543 |
|||||
|
I. Capital and Funds |
7,151 |
5,329 |
|||||
|
1. Working capital |
6,344 |
4,572 |
|||||
|
2. Differences from asset revaluation |
0 |
0 |
|||||
|
3. Exchange rate differences |
0 |
0 |
|||||
|
4. Development investment funds |
690 |
690 |
|||||
|
5. Reserved funds |
0 |
0 |
|||||
|
6. Retained profit |
50 |
0 |
|||||
|
7. Construction capital sources |
67 |
67 |
|||||
|
II. Other administrative and fund sources |
120 |
214 |
|||||
|
1. Provident funds for unemployment |
0 |
0 |
|||||
|
2. Reward and welfare funds |
120 |
214 |
|||||
|
3. Management funds of higher level |
0 |
0 |
|||||
|
4. Functional operation funds |
0 |
0 |
|||||
|
5. Fund sources formed by fixed assets |
0 |
0 |
|||||
|
TOTAL LIABILITY
AND EQUITY |
58,539 |
48,631 |
|||||
|
|
|||||||
|
PROFIT & LOSE
STATEMENT |
||
|
|
||
|
Description |
FY 2004
|
FY 2003 |
|
Total
revenue |
134,801 |
124,278 |
|
Deductions Items |
1,912 |
1,589 |
|
- Discount |
1,552 |
1,197 |
|
- Devaluation |
1 |
0 |
|
- Return of sold goods |
359 |
11 |
|
- Turnover tax, Luxury tax & Export tax |
0 |
381 |
|
1. Net revenue |
132,889 |
122,689 |
|
2. Cost of goods sold |
121,916 |
111,201 |
|
3. Gross Profit |
10,973 |
11,488 |
|
4. Sales expenses |
6,287 |
6,148 |
|
5. |
4,245 |
4,192 |
|
6. Net income from business activities |
441 |
1,148 |
|
Income from financial activities |
552 |
742 |
|
Expenditure from financial activities |
1,908 |
1,645 |
|
7. Net income
from financial operation |
-1,356 |
-903 |
|
Irregular income |
1,170 |
358 |
|
Irregular expenditure |
35 |
3 |
|
8. Irregular
Profit |
1,135 |
355 |
|
9. Total pre-tax
profit |
220 |
600 |
|
10. Income tax |
61 |
192 |
|
11. After tax
profit |
159 |
408 |
|
|
||
|
|
||
|
FINANCIAL FACTORS |
||
|
|
||
|
Description |
FY 2004 |
FY 2003 |
|
Current liquidity ratio |
1.09 |
1.04 |
|
Quick Liquidity ratio |
0.60 |
0.59 |
|
Inventory circle |
5.57 |
11.71 |
|
Average receive period |
74.94 |
64.79 |
|
Utilizing Asset Performance |
2.27 |
2.52 |
|
Liability/ Total Asset (%) |
87.58 |
88.60 |
|
Liability/ Owner's equity (%) |
705.10 |
777.34 |
|
Income before tax/ Total asset (%) ROA |
0.38 |
1.23 |
|
Income before tax/ Owner's equity (%) ROE |
3.03 |
10.82 |
|
Gross Profit / Total revenue (%) GPM |
8.14 |
9.24 |
|
Income before tax/ Total revenue (%) NPM |
0.16 |
0.48 |
|
|
||
|
|
||
|
INTERPRETATION |
||
|
The subject was a State owned company. It was established in 1997 under the decision of Quang Ngai People’s Committee. The business of the subject was to trade in pharmaceutical products and produced basic chemical medicines to supply for local market. In January 2005, the subject was officially transformed to a Joint stock company but the State is still keeping right of control with 51 percent of shares. The position in the industry of the subject is good. The premises of the subject are average. The subject now
focuses on trading in pharmaceutical for local market such as village
hospitals, and district hospitals. The subject has already won a contract to
supply medial materials and pharmaceuticals for local hospital. The market
share of the subject seems fairly good. It mainly distributes products in
Quang In general, the financial and operational status of the subject is regarded rather good. Its business operation is stable but with a slow rate of development. The subject has capacity to meet financial commitments. No caution needed for small and normal business transactions. |
||
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average/normal. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)